Kineta Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 4

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

Kineta General Information

Description

Kineta Inc is a clinical stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients' lives. The company has leveraged its expertise in innate immunity and is focused on discovering and developing potentially differentiated immunotherapies that address the mechanisms of cancer immune resistance.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 219 Terry Avenue North
  • Suite 300
  • Seattle, WA 98109
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 219 Terry Avenue North
  • Suite 300
  • Seattle, WA 98109
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kineta Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
31. Merger/Acquisition 30-Jun-2025 Completed Generating Revenue
30. PIPE 05-Oct-2023 Completed Generating Revenue
29. PIPE 25-Apr-2023 Completed Generating Revenue
28. PIPE 19-Dec-2022 Completed Generating Revenue
27. Reverse Merger 16-Dec-2022 Completed Generating Revenue
26. Later Stage VC 25-Feb-2022 Completed Generating Revenue
25. Later Stage VC 24-Nov-2021 Completed Generating Revenue
24. Later Stage VC 04-Oct-2021 Completed Generating Revenue
23. Later Stage VC 05-May-2020 $7.95M $82.9M Completed Generating Revenue
22. Debt - PPP 15-Apr-2020 $890K $75M Completed Generating Revenue
To view Kineta’s complete valuation and funding history, request access »

Kineta Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Kineta Inc is a clinical stage biotechnology company with a mission to develop next-generation immunotherapies that tran
Drug Discovery
Seattle, WA
4 As of 2024

Lexington, MA
 

Bothell, WA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kineta Competitors (48)

One of Kineta’s 48 competitors is Agenus, a Formerly VC-backed company based in Lexington, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Agenus Formerly VC-backed Lexington, MA
LeonaBio Formerly VC-backed Bothell, WA
CytomX Therapeutics Formerly VC-backed South San Francisco, CA
Affimed Formerly VC-backed Mannheim, Germany
Marengo Therapeutics Venture Capital-Backed Cambridge, MA
You’re viewing 5 of 48 competitors. Get the full list »

Kineta Patents

Kineta Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023107630-A2 Amino alcohol compounds and uses thereof Inactive 08-Dec-2021
WO-2023107630-A3 Amino alcohol compounds and uses thereof Inactive 08-Dec-2021
WO-2023107547-A2 Azetidine and spiroazetidine compounds and uses thereof Inactive 08-Dec-2021
WO-2023107547-A3 Azetidine and spiroazetidine compounds and uses thereof Inactive 08-Dec-2021
AU-2022407047-A1 Bicyclic heteroarenes and methods of their use Pending 08-Dec-2021 C07D519/00
To view Kineta’s complete patent history, request access »

Kineta Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kineta Former Investors (27)

Investor Name Investor Type Holding Investor Since Participating Rounds
American Research Capital Corporation Minority
AngelMD Angel Group Minority
Cantilever Investors Venture Capital Minority
Growth and Value Development Inc. Venture Capital Minority
Humedix Corporation Minority
You’re viewing 5 of 27 investors. Get the full list »

Kineta Acquisitions (1)

Kineta’s most recent deal was a Merger/Acquisition with Yumanity Therapeutics. The deal was made on 16-Dec-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Yumanity Therapeutics 16-Dec-2022 Merger/Acquisition Drug Discovery
To view Kineta’s complete acquisitions history, request access »

Kineta ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Kineta’s complete esg history, request access »

Kineta FAQs

  • When was Kineta founded?

    Kineta was founded in 2006.

  • Where is Kineta headquartered?

    Kineta is headquartered in Seattle, WA.

  • What is the size of Kineta?

    Kineta has 4 total employees.

  • What industry is Kineta in?

    Kineta’s primary industry is Drug Discovery.

  • Is Kineta a private or public company?

    Kineta is a Private company.

  • What is Kineta’s current revenue?

    The current revenue for Kineta is .

  • How much funding has Kineta raised over time?

    Kineta has raised $138M.

  • Who are Kineta’s investors?

    American Research Capital, AngelMD, Cantilever Investors, Growth and Value Development Inc., and Humedix are 5 of 27 investors who have invested in Kineta.

  • Who are Kineta’s competitors?

    Agenus, LeonaBio, CytomX Therapeutics, Affimed, and Marengo Therapeutics are some of the 48 competitors of Kineta.

  • When was Kineta acquired?

    Kineta was acquired on 30-Jun-2025.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process